Neurocrine Biosciences Inc (NASDAQ:NBIX)

101.79
Delayed Data
As of Jun 22
 -1.66 / -1.60%
Today’s Change
44.75
Today|||52-Week Range
106.26
+31.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Revenue and IncomeNet Revenues6.3M60.8M94.5M71.1M
 
 
 
 
 
Cost of Goods Sold61.0K433.0K54.0K164.0K
 
 
 
 
 
Depreciation And Amortization589.0K616.0K706.0K786.0K
 
 
 
 
 
 
Operating ExpensesGross Income5.7M59.7M93.8M70.1M
 
 
 
 
 
General Expenses63.0M65.7M81.9M107.6M
 
 
 
 
 
Research And Development21.9M22.5M25.6M48.9M
 
 
 
 
 
Total Operating Expenses63.6M66.8M82.7M108.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-57.3M-6.0M11.8M-37.4M
 
 
 
 
 
Interest Expense On Debt4.8M7.3M7.4M7.5M
 
 
 
 
 
Other Expenses881.0K188.0K156.0K201.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-60.0M-11.1M6.9M-41.8M
 
 
 
 
 
Net Income-60.0M-11.1M6.9M-41.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS88.1M88.3M88.7M89.5M
 
 
 
 
 
Shares To Calculate EPS Diluted88.1M88.3M92.7M89.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.68-$0.13$0.07-$0.47
 
 
 
 
 
EPS Diluted-$0.68-$0.13$0.07-$0.47